Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs
- First Online:
- Cite this article as:
- Jähnichen, S., Glusa, E. & Pertz, H.H. Naunyn-Schmiedeberg's Arch Pharmacol (2005) 371: 89. doi:10.1007/s00210-004-1006-6
This study characterizes the relaxant response to 5-hydroxytryptamine (5-HT) in prostaglandin F2α (PGF2α)-precontracted pulmonary arteries of weaned pigs. In arterial rings with intact endothelium, the relaxation to 5-HT was biphasic. The high affinity component of relaxation to 5-HT (0.1–10 nM) was abolished by mechanical removal of the endothelium or after the addition of l-NAME (200 μM), and was inhibited by the 5-HT2B/2C receptor antagonist SB 206553 (1 μM), but not the 5-HT2C receptor antagonist SB 242084 (0.1 μM). Endothelium-intact arteries were also relaxed by the selective 5-HT2B receptor agonist BW 723C86 (pD2 7.7). The relaxant response to BW 723C86 was inhibited by 1 μM SB 206553 (pKB 6.8). The low affinity component of relaxation to 5-HT (≥30 nM) remained unaffected after mechanical removal of the endothelium or the addition of l-NAME. In endothelium-denuded arterial rings, 5-HT, 5-carboxamidotryptamine (5-CT), 5-methoxytryptamine (5-MeOT), and frovatriptan produced monophasic relaxations with pD2 values of 6.5, 7.5, 5.9, and 4.7 respectively. Relaxant responses to the agonists were antagonized by the selective 5-HT7 receptor antagonist SB 269970 (pKB 8.2–8.9). The relaxant response to the potent 5-HT7 receptor agonist 5-CT was also antagonized by methiothepin (pKB 9.6), pimozide (pKB 8.2), mesulergine (pKB 7.7), methysergide (pKB 7.4), clozapine (pKB 7.6), and spiperone (pKB 7.4). The estimated pKB values argue in favor of an involvement of 5-HT7 receptors in the direct vasorelaxant action of 5-HT in the pulmonary arteries of weaned pigs. The relaxant response to 5-CT was associated with an increase in cAMP that was surmountably antagonized by SB 269970 (pKB 8.6). The present in vitro bioassay can be used to characterize new drugs with potential agonist or antagonist properties at functional 5-HT7 receptors.